National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Childhood Rhabdomyosarcoma Treatment (PDQ®)
Patient VersionHealth Professional VersionEn españolLast Modified: 11/25/2009
Table 2. COG-STS Pretreatment Staging System

Stage   Sites of Primary Tumor  T Stage  Tumor Size  Regional Lymph Nodes  Distant Metastasis 
I Favorable sites T1 or T2 Any size N0 or N1 or NX M0
II Unfavorable sites T1 or T2 a, ≤ 5 cm N0 or NX M0
III Unfavorable sites T1 or T2 a, ≤ 5 cm N1 M0
b, > 5 cm N0 or N1 or NX
IV Any site T1 or T2 Any size N0 or N1 or NX M1
M0 = absence of metastatic spread; M1 = presence of metastatic spread beyond the primary site; N0 = absence of nodal spread; N1 = presence of nodal spread beyond the primary site; X = unknown N status.


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov